Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Conteh MA, Goldstein ST, Wurie HR, Gidudu J, Lisk DR, Carter RJ, Seward JF, Hampton LM, Wang D, Andersen LE, Arvay M, Schrag SJ, Dawson P, Fombah AE, Petrie CR, Feikin DR, Russell JBW, Lindblad R, Kargbo SAS, Samai M, Mahon BE.

J Infect Dis. 2018 May 18;217(suppl_1):S33-S39. doi: 10.1093/infdis/jiy061.

2.

Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Jarrett OD, Seward JF, Fombah AE, Lindblad R, Jalloh MI, El-Khorazaty J, Dawson P, Burton D, Zucker J, Carr W, Bah MM, Deen GF, George PM, James F, Lisk DR, Pratt D, Russell JBW, Sandy JD, Turay P, Hamel MJ, Schrag SJ, Walker RE, Samai M, Goldstein ST.

J Infect Dis. 2018 May 18;217(suppl_1):S24-S32. doi: 10.1093/infdis/jiy042.

3.

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson MA, Jalloh MI, Schrag SJ, Idriss A, Carter RJ, Dawson P, Kargbo SAS, Leigh B, Bawoh M, Legardy-Williams J, Deen G, Carr W, Callis A, Lindblad R, Russell JBW, Petrie CR, Fombah AE, Kargbo B, McDonald W, Jarrett OD, Walker RE, Gargiullo P, Bash-Taqi D, Gibson L, Fofanah AB, Schuchat A; STRIVE Study Team.

J Infect Dis. 2018 May 18;217(suppl_1):S6-S15. doi: 10.1093/infdis/jiy020. Erratum in: J Infect Dis. 2018 Jul 2;218(3):508-507.

4.

Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Fombah AE, Goldstein ST, Jarrett OD, Jalloh MI, El-Khorazaty J, Lisk DR, Legardy-Williams J, Pratt DA, George PM, Russell JBW, Schrag SJ, Dawson P, Deen GF, Carr W, Lindblad R, James F, Bah MM, Yillia JF, Sandy JD, Turay PE, Conteh MA, Slutsker L, Mahon BE, Samai M, Seward JF.

J Infect Dis. 2018 May 18;217(suppl_1):S75-S80. doi: 10.1093/infdis/jix603.

5.

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.

Zhu FC, Wurie AH, Hou LH, Liang Q, Li YH, Russell JB, Wu SP, Li JX, Hu YM, Guo Q, Xu WB, Wurie AR, Wang WJ, Zhang Z, Yin WJ, Ghazzawi M, Zhang X, Duan L, Wang JZ, Chen W.

Lancet. 2017 Feb 11;389(10069):621-628. doi: 10.1016/S0140-6736(16)32617-4. Epub 2016 Dec 23.

PMID:
28017399
6.

Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.

Sahr F, Ansumana R, Massaquoi TA, Idriss BR, Sesay FR, Lamin JM, Baker S, Nicol S, Conton B, Johnson W, Abiri OT, Kargbo O, Kamara P, Goba A, Russell JB, Gevao SM.

J Infect. 2017 Mar;74(3):302-309. doi: 10.1016/j.jinf.2016.11.009. Epub 2016 Nov 17.

PMID:
27867062
7.

Implementing an Ebola Vaccine Study - Sierra Leone.

Widdowson MA, Schrag SJ, Carter RJ, Carr W, Legardy-Williams J, Gibson L, Lisk DR, Jalloh MI, Bash-Taqi DA, Kargbo SA, Idriss A, Deen GF, Russell JB, McDonald W, Albert AP, Basket M, Callis A, Carter VM, Ogunsanya KR, Gee J, Pinner R, Mahon BE, Goldstein ST, Seward JF, Samai M, Schuchat A.

MMWR Suppl. 2016 Jul 8;65(3):98-106. doi: 10.15585/mmwr.su6503a14.

PMID:
27387395
8.

A Compartmentalized Profibrotic Immune Response Characterizes Pericardial Tuberculosis, Irrespective of HIV-1 Infection.

Matthews K, Deffur A, Ntsekhe M, Syed F, Russell JB, Tibazarwa K, Wolske J, Brink J, Mayosi BM, Wilkinson RJ, Wilkinson KA.

Am J Respir Crit Care Med. 2015 Dec 15;192(12):1518-21. doi: 10.1164/rccm.201504-0683LE. No abstract available.

9.

Towards host-directed therapies for tuberculosis.

Zumla A, Maeurer M; Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS.

Nat Rev Drug Discov. 2015 Aug;14(8):511-2. doi: 10.1038/nrd4696. Epub 2015 Jul 17.

PMID:
26184493
10.

Posterior Reversible Encephalopathy Syndrome and Eclampsia in a Primigravid Woman: The First Reported Case from Sierra Leone.

Russell JB, Gibril A, Dahniya H, Lisk DR.

West Afr J Med. 2015 Jul-Sep;34(3):197-200.

PMID:
28276046
11.

Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.

Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, Pogue J, Thabane L, Smieja M, Francis V, Joldersma L, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Chitsa Banda A, Brown B, Manga P, Kirenga B, Mondo C, Mntla P, Tsitsi JM, Peters F, Essop MR, Russell JB, Hakim J, Matenga J, Barasa AF, Sani MU, Olunuga T, Ogah O, Ansa V, Aje A, Danbauchi S, Ojji D, Yusuf S; IMPI Trial Investigators.

N Engl J Med. 2014 Sep 18;371(12):1121-30. doi: 10.1056/NEJMoa1407380. Epub 2014 Sep 1.

12.

Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

Mayosi BM, Ntsekhe M, Bosch J, Pogue J, Gumedze F, Badri M, Jung H, Pandie S, Smieja M, Thabane L, Francis V, Thomas KM, Thomas B, Awotedu AA, Magula NP, Naidoo DP, Damasceno A, Banda AC, Mutyaba A, Brown B, Ntuli P, Mntla P, Ntyintyane L, Ramjee R, Manga P, Kirenga B, Mondo C, Russell JB, Tsitsi JM, Peters F, Essop MR, Barasa AF, Mijinyawa MS, Sani MU, Olunuga T, Ogah O, Adebiyi A, Aje A, Ansa V, Ojji D, Danbauchi S, Hakim J, Matenga J, Yusuf S.

Am Heart J. 2013 Feb;165(2):109-15.e3. doi: 10.1016/j.ahj.2012.08.006. Epub 2012 Dec 13.

PMID:
23351812
13.

Lessons from the cow: what the ruminant animal can teach us about consolidated bioprocessing of cellulosic biomass.

Weimer PJ, Russell JB, Muck RE.

Bioresour Technol. 2009 Nov;100(21):5323-31. doi: 10.1016/j.biortech.2009.04.075. Epub 2009 Jun 26. Review.

PMID:
19560344
14.

Bovicin HC5 inhibits wasteful amino acid degradation by mixed ruminal bacteria in vitro.

Lima JR, Ribon Ade O, Russell JB, Mantovani HC.

FEMS Microbiol Lett. 2009 Mar;292(1):78-84. doi: 10.1111/j.1574-6968.2008.01474.x. Epub 2009 Jan 16.

15.

The ability of non-bacteriocin producing Streptococcus bovis strains to bind and transfer bovicin HC5 to other sensitive bacteria.

Xavier BM, Russell JB.

Anaerobe. 2009 Aug;15(4):168-72. doi: 10.1016/j.anaerobe.2008.10.002. Epub 2009 Jan 3.

PMID:
19171197
16.

Quantitative analysis of cellulose degradation and growth of cellulolytic bacteria in the rumen.

Russell JB, Muck RE, Weimer PJ.

FEMS Microbiol Ecol. 2009 Feb;67(2):183-97. doi: 10.1111/j.1574-6941.2008.00633.x. Review.

17.

Abnormal diastolic and systolic septal motion following pericardiectomy demonstrated by ciné DENSE MRI.

Spottiswoode B, Russell JB, Moosa S, Meintjes EM, Epstein FH, Mayosi BM.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):208-9.

18.

Tuberculous effusive-constrictive pericarditis.

Russell JB, Syed FF, Ntsekhe M, Mayosi BM, Moosa S, Tshifularo M, Smedema JP.

Cardiovasc J Afr. 2008 Jul-Aug;19(4):200-1.

19.

The activity and stability of cell-associated activity of bovicin HC5, a bacteriocin from Streptococcus bovis HC5.

Xavier BM, Houlihan AJ, Russell JB.

FEMS Microbiol Lett. 2008 Jun;283(2):162-6. doi: 10.1111/j.1574-6968.2008.01155.x. Epub 2008 Apr 24.

20.

Bovicin HC5, a lantibiotic produced by Streptococcus bovis HC5, catalyzes the efflux of intracellular potassium but not ATP.

Mantovani HC, Russell JB.

Antimicrob Agents Chemother. 2008 Jun;52(6):2247-9. doi: 10.1128/AAC.00109-08. Epub 2008 Mar 17.

21.

Cardiovascular effects in adolescents while they are playing video games: a potential health risk factor?

Borusiak P, Bouikidis A, Liersch R, Russell JB.

Psychophysiology. 2008 Mar;45(2):327-32. Epub 2007 Nov 7.

PMID:
17995909
22.

The energy spilling reactions of bacteria and other organisms.

Russell JB.

J Mol Microbiol Biotechnol. 2007;13(1-3):1-11. Review.

23.

Characterization of a family 45 glycosyl hydrolase from Fibrobacter succinogenes S85.

Seon Park J, Russell JB, Wilson DB.

Anaerobe. 2007 Apr;13(2):83-8. Epub 2007 Jan 11.

PMID:
17292641
24.
26.

The effect of calcium and magnesium on the activity of bovicin HC5 and nisin.

Houlihan AJ, Russell JB.

Curr Microbiol. 2006 Nov;53(5):365-9. Epub 2006 Oct 11.

PMID:
17036211
28.

The use of organic acids to combat Salmonella in poultry: a mechanistic explanation of the efficacy.

Van Immerseel F, Russell JB, Flythe MD, Gantois I, Timbermont L, Pasmans F, Haesebrouck F, Ducatelle R.

Avian Pathol. 2006 Jun;35(3):182-8. Review.

PMID:
16753609
29.

Enrichment of fusobacteria from the rumen that can utilize lysine as an energy source for growth.

Russell JB.

Anaerobe. 2005 Jun;11(3):177-84. Epub 2005 Feb 16.

PMID:
16701548
30.

Factors affecting lysine degradation by ruminal fusobacteria.

Russell JB.

FEMS Microbiol Ecol. 2006 Apr;56(1):18-24.

33.

Transcriptional regulation of beta-glucanase activity in the ruminal bacterium, Prevotella bryantii B14.

Fields MW, Russell JB.

Curr Microbiol. 2005 Mar;50(3):155-9. Epub 2005 Mar 15.

PMID:
15883874
34.
36.

Effect of pH on the activity of bovicin HC5, a bacteriocin from Streptococcus bovis HC5.

Houlihan AJ, Mantovani HC, Russell JB.

FEMS Microbiol Lett. 2004 Feb 9;231(1):27-32.

37.
38.

Inhibition of Listeria monocytogenes by bovicin HC5, a bacteriocin produced by Streptococcus bovis HC5.

Mantovani HC, Russell JB.

Int J Food Microbiol. 2003 Dec 15;89(1):77-83.

PMID:
14580975
39.

The susceptibility of ionophore-resistant Clostridium aminophilum F to other antibiotics.

Houlihan AJ, Russell JB.

J Antimicrob Chemother. 2003 Oct;52(4):623-8. Epub 2003 Sep 1.

PMID:
12951349
40.

Ability of lysozyme and 2-deoxyglucose to differentiate human and bovine Streptococcus bovis strains.

Kurtovic A, Jarvis GN, Mantovani HC, Russell JB.

J Clin Microbiol. 2003 Aug;41(8):3951-4.

41.

Ionophore resistance of ruminal bacteria and its potential impact on human health.

Russell JB, Houlihan AJ.

FEMS Microbiol Rev. 2003 Apr;27(1):65-74. Review.

43.

The effect of a ruminal nitrogen (N) deficiency in dairy cows: evaluation of the cornell net carbohydrate and protein system ruminal N deficiency adjustment.

Ruiz R, Tedeschl LO, Marini JC, Fox DG, Pell AN, Jarvis G, Russell JB.

J Dairy Sci. 2002 Nov;85(11):2986-99.

PMID:
12487464
44.

The binding and degradation of nisin by mixed ruminal bacteria.

Lee SS, Mantovani HC, Russell JB.

FEMS Microbiol Ecol. 2002 Dec 1;42(3):339-45. doi: 10.1111/j.1574-6941.2002.tb01023.x.

45.

The effect of bovicin HC5, a bacteriocin from Streptococcus bovis HC5, on ruminal methane production in vitro.

Lee SS, Hsu JT, Mantovani HC, Russell JB.

FEMS Microbiol Lett. 2002 Nov 19;217(1):51-5.

46.

Factors affecting the antibacterial activity of the ruminal bacterium, Streptococcus bovis HC5.

Mantovani HC, Russell JB.

Curr Microbiol. 2003 Jan;46(1):18-23.

PMID:
12432458
47.

Bovicin HC5, a bacteriocin from Streptococcus bovis HC5.

Mantovani HC, Hu H, Worobo RW, Russell JB.

Microbiology. 2002 Nov;148(Pt 11):3347-3352. doi: 10.1099/00221287-148-11-3347.

PMID:
12427926
48.

Amino acid deamination by ruminal Megasphaera elsdenii strains.

Rychlik JL, LaVera R, Russell JB.

Curr Microbiol. 2002 Nov;45(5):340-5.

PMID:
12232664
49.

The bacteriocins of ruminal bacteria and their potential as an alternative to antibiotics.

Russell JB, Mantovani HC.

J Mol Microbiol Biotechnol. 2002 Jul;4(4):347-55. Review.

PMID:
12125815

Supplemental Content

Loading ...
Support Center